Danielle Guerrero

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform

Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform Read More »

The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP® to Deliver AI-enabled Diagnostics

Albuquerque, NM, October 30, 2024 – The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered with Indica Labs to implement digital primary diagnostics with integrated AI-powered image analysis.

The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP® to Deliver AI-enabled Diagnostics Read More »

Enhancing Patient Care with Seamless Clinical Collaboration: Streamlining Tumor Boards and MDTs with the Tumor Board Functionality of HALO AP® and HALO AP Dx

With the HALO AP platforms and their dedicated Tumor Board functionalities, pathologists can enhance multidisciplinary communication and improve treatment planning.

Enhancing Patient Care with Seamless Clinical Collaboration: Streamlining Tumor Boards and MDTs with the Tumor Board Functionality of HALO AP® and HALO AP Dx Read More »

Scroll to Top